Full-dose CHOP chomotherapy in elderly patients with non-Hodgkin's lymphoma

被引：0
|
作者：
Epeilbaum, R.
Hain, N.
Leblor, M.
Ben-Shahar, M.
Ben-Arie, Y.
Dror, Y.
Faraggi, D.
机构：
来源：
Acta Oncologica | / 34卷 / 01期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma
    Limat, S
    Demesmay, K
    Voillat, L
    Bernard, Y
    Deconinck, E
    Brion, A
    Sabbah, A
    Woronoff-Lemsi, MC
    Cahn, JY
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 277 - 281
  • [42] Update on the activity of rituximab/CHOP combinations in non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 209 - 211
  • [43] Treatment of non-Hodgkin's lymphoma in the elderly: An update
    Tirelli, U
    Zagonel, V
    Errante, D
    Fratino, L
    Monfardini, S
    HEMATOLOGICAL ONCOLOGY, 1998, 16 (01) : 1 - 13
  • [44] ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors
    Boleti, E.
    Mead, G. M.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 376 - 380
  • [45] Successful Use of Full-Dose Dexamethasone, High-Dose Cytarabine, and Cisplatin as Part of Initial Therapy in Non-Hodgkin and Hodgkin Lymphoma with Severe Hepatic Dysfunction
    McCarthy, Jeanne
    Gopal, Ajay K.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (02): : 167 - 170
  • [46] Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma
    Kilickap, Saadettin
    Yavuz, Bunyamin
    Aksoy, Sercan
    Sahiner, Levent
    Harputluoglu, Hakan
    Dincer, Murat
    Erman, Mustafa
    Aytemir, Kudret
    Tokgozoglu, Lale
    Barista, Ibrahim
    ANNALS OF ONCOLOGY, 2006, 17 : 202 - 202
  • [47] Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma
    Kilickap, Saadettin
    Yavuz, Bunyamin
    Aksoy, Sercan
    Sahiner, Levent
    Dincer, Murat
    Harputluoglu, Hakan
    Erman, Mustafa
    Aytemir, Kudret
    Tokgozoglu, Lale
    Barista, Ibrahim
    MEDICAL ONCOLOGY, 2008, 25 (04) : 437 - 442
  • [48] Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma
    Chamorey, E
    Gressin, R
    Peyrade, F
    Rossi, JF
    Lepeu, G
    Foussard, C
    Harrousseau, JL
    Fabbro, M
    Richard, B
    Delwail, V
    Maisonneuve, H
    Vilque, JP
    Thyss, A
    ONCOLOGY, 2005, 69 (01) : 19 - 26
  • [49] Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin’s lymphoma
    Saadettin Kilickap
    Bunyamin Yavuz
    Sercan Aksoy
    Levent Sahiner
    Murat Dincer
    Hakan Harputluoglu
    Mustafa Erman
    Kudret Aytemir
    Lale Tokgozoglu
    Ibrahim Barista
    Medical Oncology, 2008, 25 : 437 - 442
  • [50] Differences in efficacy and tolerance in elderly patients with intermediate grade lymphoma (NHL) treated with full-dose CHOP and GM-CSF.
    Gomez, H
    Santillana, S
    Casanova, L
    Mas, L
    Valdivia, S
    Otero, J
    Rodriguez, W
    Carracedo, C
    Vallejos, C
    BLOOD, 1995, 86 (10) : 3239 - 3239
12345